Hong Kong, September 23, 2022 – (ACN Newswire) – – A Chinese Leading Provider of Digital Health Service Solutions – Mediwelcome Healthcare Management and Technology Co., Ltd. (“Mediwelcome” or the “Company” and together with its subsidiaries the “Group”) (Securities Code: 2159) has announced its unaudited consolidated interim results for the six months ended. June 30, 2022 (“reporting period” or “first half of 2022”).

In the first half of 2022, Mediwelcome experienced contraction in revenue and other aspects to varying degrees due to continued lockdowns in many provinces in response to the severe pandemic in China. In the first half of 2022, Mediwelcome’s revenue fell by approximately 49.2% to approximately RMB 172.5 million Yoi.Gross profit is approximately 17.3 million RMBDuring the reporting period, the Group’s main revenues were generated from medical conference services, marketing strategy and consulting services, patient education and screening services, among others.

Continuously expanding medical digital marketing solutions and online healthcare platform, striving for digital upgrade

Although the economic environment faces great challenges under the epidemic situation, Mediwelcome always insists on continuously expanding and integrating integrated healthcare marketing solutions, developing an online healthcare platform and expanding business We are working together to fully implement the digital upgrade ofDuring the reporting period, medical conferencing services were the primary source of revenue, with approximately 111.3 million RMB, accounting for 64.5% of total revenue. To enhance the group’s meeting management capabilities, Mediwelcome launched the Conference+ app for medical NGOs and pharmaceutical companies to submit onsite meeting requests and monitor meeting conduct. In terms of marketing strategy and consulting services, the Group assisted pharmaceutical companies in formulating and implementing effective business strategies to increase awareness of physician brands and products through this service.During the reporting period, marketing strategy and consulting services RMB 41.3 million, accounting for 23.9% of total revenue.Patient education and screening services and CRO services are available at approximately 14.3 million RMB When 3.7 million RMBaccounting for 8.3% and 2.1% of total revenue, respectively.

Current June 2022, the group has developed and iterated multiple medical digital marketing platforms and products to provide customers with customized medical digital marketing solutions. This includes the Giraffe Smart Medical Platform, Digital Patient Management. platform, e-conferenceKirin Live, Dear Class, E-Creation, E-Insight and other products.like June 30, 2022the digital platform enrolled 384,965 registered physician users, held 46,518 online educational sessions with physicians and 25,687 online educational sessions for patients, 4,855 live-streamed and 6,319 videos available was viewed by 1,086,328 visitors.

Meanwhile, Mediwelcome has continued its efforts to develop and expand its online healthcare platform to meet the growing needs of various stakeholders in the medical field, including hospitals, doctors, pharmaceutical companies, and medical device companies. rice field. The Group’s online healthcare platform not only provides doctors and patients with consistent and high-quality online medical service solutions, but also actively develops digital management products and services for out-of-hospital chronic disease patients. .like June 30, 2022, its registered physician and patient user numbers reached 45,244 and 200,545, representing year-on-year increases of 69.9% and 321.2%, respectively.In addition, an increase in the number of active patient users purchasing prescription drugs through the Group’s Internet hospital platform led to an increase in revenues from Internet hospital services of approximately 5.6%, to approximately RMB1.9 Yoi.

Continuously upgrade the digital marketing business and seize growth opportunities to create greater value

Going forward, Mediwelcome will continue to scale up its digital marketing business and leverage its internal and external strengths and resources to further focus on developing digital marketing customers in the healthcare market. At the same time, the Group will continue its efforts to build a digital platform with accurate access for physicians and patients, using a digital integrated marketing system in which both offline and online channels are synergistic. to provide customers with integrated digital and intelligent marketing solutions. Create a closed loop for the entire process of digital manipulation. The Group will continue to upgrade its online medical platform, explore the application of AI technology, and build a closed-loop business model from in-hospital to out-of-hospital. In addition, leveraging a favorable health policy environment and unique resources, Mediwelcome will focus on expanding its business in the fields of oncology and chronic kidney disease, as well as specialized medical and marketing services in the traditional cardiovascular and cerebrovascular fields. maintain revenue growth. Ill to increase customer coverage from domestic companies.

While maintaining the scale of our business in the existing dominant therapeutic area, the Group will actively promote innovation, capture opportunities arising from the rapid expansion of demand for medical digital marketing and online healthcare, and achieve steady growth. I will continue. The Group is actively generating profits under efficient operations, while continuously expanding and developing its business model and scale to create greater value for more customers, physicians and patients.

Copyright 2022 ACN Newswire. All rights reserved.

© Japanese Company News, source JCN Press Release